Literature DB >> 14564169

Risk and prevention of transfusion-transmitted babesiosis and other tick-borne diseases.

Ritchard G Cable1, David A Leiby.   

Abstract

PURPOSE OF REVIEW: Tick-borne diseases have increasingly been recognized in the United States as public health problems. The importance of tick-borne diseases has been accelerated by increases in animal populations, as well as increased human recreation in wooded environments that are conducive to tick bites. Babesiosis, usually caused by the intraerythrocytic parasite, Babesia microti and transmitted by the same tick as Lyme disease, has important transfusion implications. Although Lyme disease has not been reported from blood transfusion, newly identified tick-borne diseases such as ehrlichiosis raise additional questions about the role of the tick in transfusion-transmitted diseases. RECENT
FINDINGS: The risk of transfusion-transmitted babesiosis is higher than usually appreciated and in endemic areas represents a major threat to the blood supply. Furthermore, the geographic range of B. microti is expanding, other Babesia spp. have been implicated in transfusion transmission in the western United States, and the movement of blood donors and donated blood components may result in the appearance of transfusion babesiosis in areas less familiar with these parasites. Consequently, a higher degree of clinical suspicion will allow early recognition and treatment of this important transfusion complication.
SUMMARY: In endemic areas transfusion-transmitted babesiosis is more prevalent than usually believed. The extension of the geographic range of various Babesia spp. and the movement of donors and blood products around the United States has resulted in the risk extending to non-endemic areas. Clinicians should maintain a high degree of clinical suspicion for transfusion-transmitted babesiosis.

Entities:  

Mesh:

Year:  2003        PMID: 14564169     DOI: 10.1097/00062752-200311000-00002

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  11 in total

1.  79-year-old man with fever, malaise, and jaundice.

Authors:  Lisa M Baumann Kreuziger; Alfonso J Tafur; Rodney L Thompson
Journal:  Mayo Clin Proc       Date:  2009-03       Impact factor: 7.616

Review 2.  Coinfections acquired from ixodes ticks.

Authors:  Stephen J Swanson; David Neitzel; Kurt D Reed; Edward A Belongia
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

Review 3.  Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti.

Authors:  David A Leiby
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

4.  Longistatin, a plasminogen activator, is key to the availability of blood-meals for ixodid ticks.

Authors:  M Khyrul Islam; M Abdul Alim; Takeharu Miyoshi; Takeshi Hatta; Kayoko Yamaji; Yasunobu Matsumoto; Kozo Fujisaki; Naotoshi Tsuji
Journal:  PLoS Pathog       Date:  2011-03-10       Impact factor: 6.823

5.  First confirmed autochthonous case of human Babesia microti infection in Europe.

Authors:  A Hildebrandt; K-P Hunfeld; M Baier; A Krumbholz; S Sachse; T Lorenzen; M Kiehntopf; H-J Fricke; E Straube
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

6.  Seroprevalence of six pathogens transmitted by the Ixodes ricinus ticks in asymptomatic individuals with HIV infection and in blood donors.

Authors:  Agnieszka Pawełczyk; Małgorzata Bednarska; Justyna D Kowalska; Beata Uszyńska-Kałuża; Marek Radkowski; Renata Welc-Falęciak
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

7.  Pathogen-reduction methods: advantages and limits.

Authors:  H G Klein; B J Bryant
Journal:  ISBT Sci Ser       Date:  2009-02-13

8.  A cysteine protease is critical for Babesia spp. transmission in Haemaphysalis ticks.

Authors:  Naotoshi Tsuji; Takeharu Miyoshi; Badger Battsetseg; Tomohide Matsuo; Xuenan Xuan; Kozo Fujisaki
Journal:  PLoS Pathog       Date:  2008-05-16       Impact factor: 6.823

9.  Chapter 4: Red cell transfusion to treat anemia in CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-08

10.  Knockout of Babesia bovis rad51 ortholog and its complementation by expression from the BbACc3 artificial chromosome platform.

Authors:  Erin A Mack; Yu-Ping Xiao; David R Allred
Journal:  PLoS One       Date:  2019-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.